These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8807046)

  • 1. Fluoroquinolone action in mycobacteria: similarity with effects in Escherichia coli and detection by cell lysate viscosity.
    Drlica K; Xu C; Wang JY; Burger RM; Malik M
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1594-9. PubMed ID: 8807046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of anaerobic growth on quinolone lethality with Escherichia coli.
    Malik M; Hussain S; Drlica K
    Antimicrob Agents Chemother; 2007 Jan; 51(1):28-34. PubMed ID: 17043118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoroquinolone action against mycobacteria: effects of C-8 substituents on growth, survival, and resistance.
    Dong Y; Xu C; Zhao X; Domagala J; Drlica K
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2978-84. PubMed ID: 9797236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
    Chen CR; Malik M; Snyder M; Drlica K
    J Mol Biol; 1996 May; 258(4):627-37. PubMed ID: 8636997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin.
    Vacher S; Pellegrin JL; Leblanc F; Fourche J; Maugein J
    J Antimicrob Chemother; 1999 Nov; 44(5):647-52. PubMed ID: 10552981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
    Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
    Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of reactive oxygen species in the action of ciprofloxacin against Escherichia coli.
    Goswami M; Mangoli SH; Jawali N
    Antimicrob Agents Chemother; 2006 Mar; 50(3):949-54. PubMed ID: 16495256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship of fluoroquinolone in Escherichia coli.
    Lee S; Park T; Lee Y
    Arch Pharm Res; 1998 Apr; 21(2):106-12. PubMed ID: 9875416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary study of the in vitro activity of irloxacin against mycobacteria.
    Casal M; Gutierrez J; Ruiz P; Moreno G
    Chemotherapy; 1995; 41(3):204-7. PubMed ID: 7656667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: effects of a C-8 methoxyl group on survival in liquid media and in human macrophages.
    Zhao BY; Pine R; Domagala J; Drlica K
    Antimicrob Agents Chemother; 1999 Mar; 43(3):661-6. PubMed ID: 10049284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of different classes of inhibitors on DNA gyrase from Mycobacterium smegmatis.
    Chatterji M; Unniraman S; Mahadevan S; Nagaraja V
    J Antimicrob Chemother; 2001 Oct; 48(4):479-85. PubMed ID: 11581225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of fluoroquinolone activity by C-8 halogen and methoxy moieties: action against a gyrase resistance mutant of Mycobacterium smegmatis and a gyrase-topoisomerase IV double mutant of Staphylococcus aureus.
    Lu T; Zhao X; Li X; Drlica-Wagner A; Wang JY; Domagala J; Drlica K
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2703-9. PubMed ID: 11557458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonradioactive single-strand conformation polymorphism analysis for detection of fluoroquinolone resistance in mycobacteria.
    Sougakoff W; Lemaître N; Cambau E; Szpytma M; Revel V; Jarlier V
    Eur J Clin Microbiol Infect Dis; 1997 May; 16(5):395-8. PubMed ID: 9228484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions.
    Cooper MA; Andrews JM; Wise R
    J Antimicrob Chemother; 1991 Sep; 28(3):399-405. PubMed ID: 1660046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital.
    Gallini A; Degris E; Desplas M; Bourrel R; Archambaud M; Montastruc JL; Lapeyre-Mestre M; Sommet A
    J Antimicrob Chemother; 2010 Dec; 65(12):2650-7. PubMed ID: 20876240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoroquinolone resistance associated with specific gyrase mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis.
    Xu C; Kreiswirth BN; Sreevatsan S; Musser JM; Drlica K
    J Infect Dis; 1996 Nov; 174(5):1127-30. PubMed ID: 8896523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria.
    Charrier C; Salisbury AM; Savage VJ; Duffy T; Moyo E; Chaffer-Malam N; Ooi N; Newman R; Cheung J; Metzger R; McGarry D; Pichowicz M; Sigerson R; Cooper IR; Nelson G; Butler HS; Craighead M; Ratcliffe AJ; Best SA; Stokes NR
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
    Zhao X; Quinn B; Kerns R; Drlica K
    J Antimicrob Chemother; 2006 Dec; 58(6):1283-6. PubMed ID: 17003060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro determination of the sensitivity of mycobacteria to fluoroquinolones].
    Dailloux M; Petitpain N; Henry C; Weber M
    Pathol Biol (Paris); 1989 May; 37(5):346-9. PubMed ID: 2780092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greater ciprofloxacin tolerance as a possible selectable phenotype underlying the pandemic spread of the H30 subclone of Escherichia coli sequence type 131.
    Johnson JR; Porter SB; Thuras P; Johnson TJ; Price LB; Tchesnokova V; Sokurenko EV
    Antimicrob Agents Chemother; 2015 Nov; 59(11):7132-5. PubMed ID: 26324269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.